Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid Bruker Corporation (BRKR)?

Page 1 of 2

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won’t accept your savings unless you commit at least $5 million) by pinpointing winning small-cap stocks. There is little or no publicly-available information at all on some of these small companies, which makes it hard for an individual investor to pin down a winner within the small-cap space. However, hedge funds and other big asset managers can do the due diligence and analysis for you instead, thanks to their highly-skilled research teams and vast resources to conduct an appropriate evaluation process. Looking for potential winners within the small-cap galaxy of stocks? We believe following the smart money is a good starting point.

Is Bruker Corporation (NASDAQ:BRKR) worth your attention right now? Hedge funds are actually taking a pessimistic view. The number of bullish hedge fund bets that are revealed through the 13F filings declined by four to 20 during the third quarter. At the end of this article we will also compare BRKR to other stocks including Brocade Communications Systems, Inc. (NASDAQ:BRCD), Healthcare Realty Trust Inc (NYSE:HR), and Cognex Corporation (NASDAQ:CGNX) to get a better sense of its popularity.

Follow Bruker Corp (NASDAQ:BRKR)
Trade (NASDAQ:BRKR) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

engineering, lab, chemistry, test, experiment, reagents, technician, protective, pharmaceutical, researching, medical, liquid, chemist, bio, laboratory, clinic, substance,

bogdanhoda/Shutterstock.com

Keeping this in mind, we’re going to take a look at the new action surrounding Bruker Corporation (NASDAQ:BRKR).

How have hedgies been trading Bruker Corporation (NASDAQ:BRKR)?

At the end of September, a total of 20 of the hedge funds tracked by Insider Monkey held long positions in Bruker Corporation, down by 17% from the second quarter of 2016. By comparison, 17 hedge funds held shares or bullish call options in BRKR heading into 2016. So, let’s examine which hedge funds were among the top holders of the stock and which hedge funds were making big moves.
BRBK
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Select Equity Group, led by Robert Joseph Caruso, holds the biggest position in Bruker Corporation (NASDAQ:BRKR). Select Equity Group has a $110.1 million position in the stock, comprising 1% of its 13F portfolio. The second largest stake is held by Cliff Asness’s AQR Capital Management, holding a $79.5 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Remaining peers that hold long positions include D. E. Shaw’s D E Shaw, Paul Marshall and Ian Wace’s Marshall Wace LLP and John Overdeck and David Siegel’s Two Sigma Advisors. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2
Loading Comments...